A phase-II study of combination of pegylated interferon alfa-2a and capecitabine in locally advanced or metastatic renal cell cancer

Research output: Contribution to journal › Article › Scientific › peer-review

10 Citations (Scopus)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{cb47c7dc655d45cc8aa784818956468c,

title = "A phase-II study of combination of pegylated interferon alfa-2a and capecitabine in locally advanced or metastatic renal cell cancer",

author = "KL Sunela and S Koskinen and P Kellokumpu-Lehtinen",

year = "2010",

doi = "10.1007/s00280-009-1134-2",

language = "English",

volume = "66",

pages = "59--67",

number = "1",

}

TY - JOUR

T1 - A phase-II study of combination of pegylated interferon alfa-2a and capecitabine in locally advanced or metastatic renal cell cancer

AU - Sunela, KL

AU - Koskinen, S

AU - Kellokumpu-Lehtinen, P

PY - 2010

Y1 - 2010

U2 - 10.1007/s00280-009-1134-2

DO - 10.1007/s00280-009-1134-2

M3 - Article

SN - 0344-5704

VL - 66

SP - 59

EP - 67

JO - Cancer Chemother Pharmacol

JF - Cancer Chemother Pharmacol

IS - 1

ER -